JAMA Network
About The Study: Researchers found in this systematic review of 155 head and neck cancer clinical trials from 2010 to 2020 that only 57% of the studies reported race or ethnicity. A comparison of these trials with the Surveillance, Epidemiology and End Results (SEER) cancer registries indicated that Black and Asian or Pacific Islander patients were underrepresented.
Authors: Linda X. Yin, M.D., of the Mayo Clinic in Rochester, Minnesota, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoto.2022.1028)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
